SMTL ID : 7cmw.2 (1 other biounit)

Complex structure of PARP1 catalytic domain with pamiparib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x DS9: (2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one(Non-covalent)

DS9.1: 11 residues within 4Å: Chain A: H.205, G.206, Y.232, Y.239, F.240, A.241, K.246, S.247, Y.250, E.331 Ligands: GOL.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:Y.232, A:Y.239, A:Y.239, A:Y.250, A:Y.250, A:Y.250 Hydrogen bonds: A:G.206, A:G.206 pi-Cation interactions: A:Y.239

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 9 residues within 4Å: Chain A: D.109, R.221, I.222, A.223, Y.232, K.236, G.237, Y.239 Ligands: DS9.1 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.109, A:A.223 GOL.3: 5 residues within 4Å: Chain A: N.110, D.113, H.205, S.207, N.211 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.110, A:S.207

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, H. et al., Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development. J.Med.Chem. (2020)

Release Date

2020-12-16

Peptides

Poly [ADP-ribose] polymerase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Poly [ADP-ribose] polymerase 1

Related Entries With Identical Sequence